Barclays PLC Neuro Pace Inc Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Barclays PLC holds 27,609 shares of NPCE stock, worth $332,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,609
Previous 20,633
33.81%
Holding current value
$332,688
Previous $144,000
114.58%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NPCE
# of Institutions
67Shares Held
21.7MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$63.5 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$41 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$30 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$29.3 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$17.9 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $299M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...